Evaluation and management of patients with heart disease and cancer: Cardio-oncology

Joerg Herrmann, Amir Lerman, Nicole P. Sandhu, Hector R Vilarraga, Sharon L. Mulvagh, Manish Kohli

Research output: Contribution to journalArticle

122 Citations (Scopus)

Abstract

The care for patients with cancer has advanced greatly over the past decades. A combination of earlier cancer diagnosis and greater use of traditional and new systemic treatments has decreased cancer-related mortality. Effective cancer therapies, however, can result in short- and long-term comorbidities that can decrease the net clinical gain by affecting quality of life and survival. In particular, cardiovascular complications of cancer treatments can have a profound effect on the health of patients with cancer and are more common among those with recognized or unrecognized underlying cardiovascular diseases. A new discipline termed cardio-oncology has thus evolved to address the cardiovascular needs of patients with cancer and optimize their care in a multidisciplinary approach. This review provides a brief introduction and background on this emerging field and then focuses on its practical aspects including cardiovascular risk assessment and prevention before cancer treatment, cardiovascular surveillance and therapy during cancer treatment, and cardiovascular monitoring and management after cancer therapy. The content of this review is based on a literature search of PubMed between January 1, 1960, and February 1, 2014, using the search terms cancer, cardiomyopathy, cardiotoxicity, cardio-oncology, chemotherapy, heart failure, and radiation.

Original languageEnglish (US)
Pages (from-to)1287-1306
Number of pages20
JournalMayo Clinic Proceedings
Volume89
Issue number9
DOIs
StatePublished - 2014

Fingerprint

Heart Neoplasms
Heart Diseases
Neoplasms
Therapeutics
Cardiomyopathies
Early Detection of Cancer
PubMed
Comorbidity
Patient Care
Cardiovascular Diseases
Heart Failure
Quality of Life
Radiation
Drug Therapy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Evaluation and management of patients with heart disease and cancer : Cardio-oncology. / Herrmann, Joerg; Lerman, Amir; Sandhu, Nicole P.; Vilarraga, Hector R; Mulvagh, Sharon L.; Kohli, Manish.

In: Mayo Clinic Proceedings, Vol. 89, No. 9, 2014, p. 1287-1306.

Research output: Contribution to journalArticle

@article{96eb1814cd054c16a62d7a29e4a7bccb,
title = "Evaluation and management of patients with heart disease and cancer: Cardio-oncology",
abstract = "The care for patients with cancer has advanced greatly over the past decades. A combination of earlier cancer diagnosis and greater use of traditional and new systemic treatments has decreased cancer-related mortality. Effective cancer therapies, however, can result in short- and long-term comorbidities that can decrease the net clinical gain by affecting quality of life and survival. In particular, cardiovascular complications of cancer treatments can have a profound effect on the health of patients with cancer and are more common among those with recognized or unrecognized underlying cardiovascular diseases. A new discipline termed cardio-oncology has thus evolved to address the cardiovascular needs of patients with cancer and optimize their care in a multidisciplinary approach. This review provides a brief introduction and background on this emerging field and then focuses on its practical aspects including cardiovascular risk assessment and prevention before cancer treatment, cardiovascular surveillance and therapy during cancer treatment, and cardiovascular monitoring and management after cancer therapy. The content of this review is based on a literature search of PubMed between January 1, 1960, and February 1, 2014, using the search terms cancer, cardiomyopathy, cardiotoxicity, cardio-oncology, chemotherapy, heart failure, and radiation.",
author = "Joerg Herrmann and Amir Lerman and Sandhu, {Nicole P.} and Vilarraga, {Hector R} and Mulvagh, {Sharon L.} and Manish Kohli",
year = "2014",
doi = "10.1016/j.mayocp.2014.05.013",
language = "English (US)",
volume = "89",
pages = "1287--1306",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "9",

}

TY - JOUR

T1 - Evaluation and management of patients with heart disease and cancer

T2 - Cardio-oncology

AU - Herrmann, Joerg

AU - Lerman, Amir

AU - Sandhu, Nicole P.

AU - Vilarraga, Hector R

AU - Mulvagh, Sharon L.

AU - Kohli, Manish

PY - 2014

Y1 - 2014

N2 - The care for patients with cancer has advanced greatly over the past decades. A combination of earlier cancer diagnosis and greater use of traditional and new systemic treatments has decreased cancer-related mortality. Effective cancer therapies, however, can result in short- and long-term comorbidities that can decrease the net clinical gain by affecting quality of life and survival. In particular, cardiovascular complications of cancer treatments can have a profound effect on the health of patients with cancer and are more common among those with recognized or unrecognized underlying cardiovascular diseases. A new discipline termed cardio-oncology has thus evolved to address the cardiovascular needs of patients with cancer and optimize their care in a multidisciplinary approach. This review provides a brief introduction and background on this emerging field and then focuses on its practical aspects including cardiovascular risk assessment and prevention before cancer treatment, cardiovascular surveillance and therapy during cancer treatment, and cardiovascular monitoring and management after cancer therapy. The content of this review is based on a literature search of PubMed between January 1, 1960, and February 1, 2014, using the search terms cancer, cardiomyopathy, cardiotoxicity, cardio-oncology, chemotherapy, heart failure, and radiation.

AB - The care for patients with cancer has advanced greatly over the past decades. A combination of earlier cancer diagnosis and greater use of traditional and new systemic treatments has decreased cancer-related mortality. Effective cancer therapies, however, can result in short- and long-term comorbidities that can decrease the net clinical gain by affecting quality of life and survival. In particular, cardiovascular complications of cancer treatments can have a profound effect on the health of patients with cancer and are more common among those with recognized or unrecognized underlying cardiovascular diseases. A new discipline termed cardio-oncology has thus evolved to address the cardiovascular needs of patients with cancer and optimize their care in a multidisciplinary approach. This review provides a brief introduction and background on this emerging field and then focuses on its practical aspects including cardiovascular risk assessment and prevention before cancer treatment, cardiovascular surveillance and therapy during cancer treatment, and cardiovascular monitoring and management after cancer therapy. The content of this review is based on a literature search of PubMed between January 1, 1960, and February 1, 2014, using the search terms cancer, cardiomyopathy, cardiotoxicity, cardio-oncology, chemotherapy, heart failure, and radiation.

UR - http://www.scopus.com/inward/record.url?scp=84937774528&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937774528&partnerID=8YFLogxK

U2 - 10.1016/j.mayocp.2014.05.013

DO - 10.1016/j.mayocp.2014.05.013

M3 - Article

C2 - 25192616

AN - SCOPUS:84937774528

VL - 89

SP - 1287

EP - 1306

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 9

ER -